Home LiteratureArticle Details
PMID: 21511185 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Immunity ·Vol. 34 ·No. 4 ·2011-04-22 ·Pages 566-78

Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Brüning JC, Müller W, Rudensky AY

Abstract

Effector CD4+ T cell subsets, whose differentiation is facilitated by distinct cytokine cues, amplify the corresponding type of inflammatory response. Regulatory T (Treg) cells integrate environmental cues to suppress particular types of inflammation. In this regard, STAT3, a transcription factor essential for T helper 17 (Th17) cell differentiation, is necessary for Treg cell-mediated control of Th17 cell responses. Here, we showed that anti-inflammatory interleukin-10 (IL-10), and not proinflammatory IL-6 and IL-23 cytokine signaling, endowed Treg cells with the ability to suppress pathogenic Th17 cell responses. Ablation of the IL-10 receptor in Treg cells resulted in selective dysregulation of Th17 cell responses and colitis similar to that observed in mice harboring STAT3-deficient Treg cells. Thus, Treg cells limit Th17 cell inflammation by serving as principal amplifiers of negative regulatory circuits operating in immune effector cells.

MeSH Terms
Animals Cell Lineage Colitis/immunology,pathology Interleukin-10/immunology,metabolism Mice Mice, Knockout Phosphorylation Receptors, Interleukin-10/deficiency,immunology STAT3 Transcription Factor/immunology,metabolism Signal Transduction T-Lymphocytes, Regulatory/cytology,immunology Th17 Cells/immunology
Chemicals
IL10 protein, mouse Receptors, Interleukin-10 STAT3 Transcription Factor Stat3 protein, mouse Interleukin-10
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Chaudhry Ashutosh
Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Samstein Robert M
Treuting Piper
Liang Yuqiong
Pils Marina C
Heinrich Jan-Michael
Jack Robert S
Wunderlich F Thomas
Brüning Jens C
Müller Werner
Rudensky Alexander Y
References (49)
49 references, click to expand
  1. Th17 and regulatory T cells in mediating and restraining inflammation.
    Cell. 2010 Mar 19;140(6):845-58 PMID: 20303875
  2. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.
    Science. 2009 Nov 13;326(5955):986-91 PMID: 19797626
  3. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.
    Nat Med. 2009 Mar;15(3):277-84 PMID: 19234462
  4. IL-17 family cytokines and the expanding diversity of effector T cell lineages.
    Annu Rev Immunol. 2007;25:821-52 PMID: 17201677
  5. The complex role of interleukin-10 in autoimmunity.
    J Autoimmun. 2003 Jun;20(4):281-5 PMID: 12791313
  6. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.
    Nat Immunol. 2009 Jun;10(6):595-602 PMID: 19412181
  7. IL-17 and Th17 Cells.
    Annu Rev Immunol. 2009;27:485-517 PMID: 19132915
  8. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.
    J Exp Med. 2004 Nov 15;200(10):1289-97 PMID: 15534372
  9. Interleukin-17 and its expanding biological functions.
    Cell Mol Immunol. 2010 May;7(3):164-74 PMID: 20383173
  10. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.
    J Exp Med. 2005 Dec 5;202(11):1539-47 PMID: 16314435
  11. The biological functions of T helper 17 cell effector cytokines in inflammation.
    Immunity. 2008 Apr;28(4):454-67 PMID: 18400188
  12. The interleukin-23 axis in intestinal inflammation.
    Immunol Rev. 2008 Dec;226:147-59 PMID: 19161422
  13. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.
    Immunity. 2008 Apr;28(4):546-58 PMID: 18387831
  14. How regulatory T cells work.
    Nat Rev Immunol. 2008 Jul;8(7):523-32 PMID: 18566595
  15. The regulation of IL-10 production by immune cells.
    Nat Rev Immunol. 2010 Mar;10(3):170-81 PMID: 20154735
  16. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.
    Nat Immunol. 2009 Sep;10(9):1000-7 PMID: 19633673
  17. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems.
    Mucosal Immunol. 2010 Sep;3(5):443-9 PMID: 20505662
  18. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.
    Nature. 2007 Feb 22;445(7130):936-40 PMID: 17237761
  19. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
    Nature. 2009 Mar 19;458(7236):351-6 PMID: 19182775
  20. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.
    J Clin Invest. 2006 May;116(5):1310-6 PMID: 16670770
  21. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.
    J Biol Chem. 2007 Mar 30;282(13):9358-9363 PMID: 17277312
  22. Interleukin-10 and related cytokines and receptors.
    Annu Rev Immunol. 2004;22:929-79 PMID: 15032600
  23. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model.
    Eur J Immunol. 2010 Feb;40(2):443-8 PMID: 19941312
  24. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Nat Immunol. 2003 Apr;4(4):330-6 PMID: 12612578
  25. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.
    Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1903-8 PMID: 19174509
  26. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
    Nat Immunol. 2007 Dec;8(12):1390-7 PMID: 17994024
  27. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells.
    Eur J Immunol. 2008 Jul;38(7):1807-13 PMID: 18506885
  28. Cytokine signaling modules in inflammatory responses.
    Immunity. 2008 Apr;28(4):477-87 PMID: 18400190
  29. Charles River altered Schaedler flora (CRASF) remained stable for four years in a mouse colony housed in individually ventilated cages.
    Lab Anim. 2009 Oct;43(4):362-70 PMID: 19535393
  30. Stability of the regulatory T cell lineage in vivo.
    Science. 2010 Sep 24;329(5999):1667-71 PMID: 20929851
  31. The Current STATus of lymphocyte signaling: new roles for old players.
    Curr Opin Immunol. 2009 Apr;21(2):161-6 PMID: 19362457
  32. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.
    Immunity. 2008 Apr;28(4):468-76 PMID: 18400189
  33. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
    N Engl J Med. 2009 Nov 19;361(21):2033-45 PMID: 19890111
  34. Biology of interleukin-10.
    Cytokine Growth Factor Rev. 2010 Oct;21(5):331-44 PMID: 21115385
  35. Understanding the IL-23-IL-17 immune pathway.
    Trends Immunol. 2006 Jan;27(1):17-23 PMID: 16290228
  36. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
    Nat Immunol. 2007 Feb;8(2):191-7 PMID: 17136045
  37. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.
    Cell Metab. 2010 Sep 8;12(3):237-49 PMID: 20816090
  38. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
    Immunity. 2009 May;30(5):636-45 PMID: 19464986
  39. Interleukin-10 and the interleukin-10 receptor.
    Annu Rev Immunol. 2001;19:683-765 PMID: 11244051
  40. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection.
    Eur J Immunol. 2009 Aug;39(8):2173-83 PMID: 19593768
  41. Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.
    Immunity. 2011 Apr 22;34(4):554-65 PMID: 21511184
  42. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.
    Nat Immunol. 2009 Nov;10(11):1178-84 PMID: 19783988
  43. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation.
    J Immunol. 2009 Aug 15;183(4):2312-20 PMID: 19620304
  44. Stat3 and Stat4 direct development of IL-17-secreting Th cells.
    J Immunol. 2007 Apr 15;178(8):4901-7 PMID: 17404271
  45. Induction of intestinal Th17 cells by segmented filamentous bacteria.
    Cell. 2009 Oct 30;139(3):485-98 PMID: 19836068
  46. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.
    Mucosal Immunol. 2010 May;3(3):239-46 PMID: 20200511
  47. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.
    Immunity. 2010 May 28;32(5):605-15 PMID: 20493732
  48. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Gut. 2009 Aug;58(8):1152-67 PMID: 19592695
  49. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.
    Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G764-78 PMID: 11518689
Article Info
Journal
Immunity
Abbr.
Immunity
ISSN
1097-4180
Published
2011-04-22
Pages
566-78
Language
English
Region
United States
NLM ID
9432918
PMCID
PMC3088485
Subset
IM
Grants
NIGMS NIH HHS · GM07739 · United States
Howard Hughes Medical Institute · United States
NIAID NIH HHS · R37 AI034206 · United States
NIDDK NIH HHS · F30 DK091968 · United States
NIGMS NIH HHS · T32 GM007739 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com